Please log in
to access more information


User name and Password not recognised

Home Page > News > APRIL 16TH, 2018

APRIL 16TH, 2018

Biom'up reports 2017 full-year results and provides corporate update


- 2017 results underscore focus on establishing a strong financial foundation as basis for commercial strategy going forward

- A total of c. €100 million raised through 2017 to date

- Marketing approval lead product HEMOBLASTTM Bellows obtained from the U.S.

FDA in December 2017, 7 months ahead of schedule

- 2018 focus on product launches, scale-up of manufacturing and hemostatic product portfolio expansion

Download the full press release below:  

» Biom'up reports 2017 EN .pdf